|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities: | |||||
| Loss for the year | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock based compensation | |||||
| Depreciation and amortization | |||||
| Impairment loss on property and equipment | |||||
| Bad debt | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Accounts receivable - related party | |||||
| Inventory | |||||
| Contract asset | |||||
| Contract asset - related party | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued liabilities | |||||
| Accounts payable and accrued liabilities - related party | |||||
| Contract liability | |||||
| Contract liability - related party | |||||
| Changes in operating lease assets and liabilities | |||||
| Net Cash used in Operating Activities | |||||
| Cash Flows From Investing Activities: | |||||
| Purchase of property and equipment | |||||
| Cash paid for asset acquisition | |||||
| Net Cash used in Investing Activities | |||||
| Cash Flows From Financing Activities: | |||||
| Proceeds from issuance of common stock units | |||||
| Proceeds from issuance of Series A preferred stock units | |||||
| Proceeds from exercise of warrants | |||||
| Proceeds from asset-based loan agreement | |||||
| Repayment of asset-based loan agreement | |||||
| Proceeds from stock payable for 10,000 shares for exercise of warrants | |||||
| Repayment of notes payable | |||||
| Dividend paid | |||||
| Net Cash provided by Financing Activities | |||||
| Net change in cash | |||||
| Cash, beginning of period | |||||
| Cash, end of period | |||||
| Supplemental cash flow information | |||||
| Cash paid for interest | |||||
| Non-cash Investing and Financing transactions: | |||||
| Capitalization of interest and fees of asset-based loan into asset-based loan liability | |||||
| Class A common stock issued for conversion of Series A convertible preferred stock | |||||
| Modification of right-of-use asset and lease liability | |||||
| Recognition of right-of-use asset and lease liability | |||||
| Class A common stock issued for exercised cashless warrant | |||||
| Warrants granted for offering underwriter cost | |||||
Loading...